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E D I T O R I A L
Evolutionary perspectives on human infectious diseases: 
Challenges, advances, and promises
1  | INTRODUC TION
Modern biomedicine has contributed remarkably to the reduction of 
infectious diseases worldwide, including the eradication of smallpox 
and the control of common childhood diseases (e.g., polio, measles, 
rubella) that once claimed millions of lives and caused suffering of 
tens of millions. This has been made possible through improved di-
agnostics, surveillance, therapeutics, vaccines, and an associated 
health system infrastructure. These achievements can be largely 
credited to advances in biomedical sciences and their application in 
the 20th century.
The spectacular advances in the biomedical sciences were in 
turn a consequence of the emergence and widespread acceptance 
of the biomedical paradigm, in which the discovery of microbes and 
establishment of ‘germ theory’ had played a central role. By the 
1960s, a sense began to prevail that infectious diseases had been 
conquered, or were at least conquerable in the case of malaria, den-
gue, and other vector- borne diseases (VBD) that appeared to be “in 
retreat.”
Yet, by the 1980s, with the appearance of the HIV/AIDS pan-
demic and followed by new antimicrobial- resistant strains of 
bacterial pathogens, confidence began to erode. Major setbacks 
also increasingly became apparent in the efforts to control 
VBDs particularly with the resurgence of malaria and dengue 
worldwide (WHO, 2016). An increasing number of historically 
localized or otherwise geographically confined VBDs began to 
spread and even jump continents, with the arrival of West Nile 
virus and Zika virus in the Americas being the most prominent of 
many examples. Such pathogens, identified decades ago in their 
native habitat and hosts as part of natural history studies, were 
long considered to be of relatively little public health concern 
or apparent impact (Lederberg, Shope, & Oaks, 1992; Packard, 
2007).
Human population growth and anthropogenic environmental 
changes, accelerating with an unprecedented intensity and scale 
particularly since the mid- 1900s, are increasingly recognized as 
underlying much of the emerging infectious diseases (EID) prob-
lem (Myers & Patz, 2009; Myers et al., 2013; Whitmee et al., 2015). 
These disease emergence drivers emblematic of the era of modern 
development can be seen as consequences of modern medical and 
hygiene interventions introduced a century earlier. Together, they 
radically modified (and continue to alter) landscapes and ecosys-
tems worldwide producing what has become a continual state of 
social, ecological, and evolutionary imbalance (McNeill, 1976). 
Among the environmental changes, global climate change has be-
come widely accepted among experts as a significant contributor 
to these imbalances that will increasingly influence infectious dis-
eases transmission, yet in ways that are difficult to predict (Altizer, 
Ostfeld, Johnson, Kutz, & Harvell, 2013; Lafferty, 2009; McMichael 
& Wilcox, 2009).
The complexity of factors and processes underlying infectious 
diseases and their transmission go well beyond the scope and an-
alytic resolution of biomedicine (and conventional biomedical 
training), requiring a complementary framing approach capable 
of acknowledging and assessing cross- scale influences, context 
dependency, and the constant ‘arms race’ between co- evolving 
organisms (Van Valen, 1973). Evolutionary biology provides these 
scientific foundations to help refine our understanding of not only 
the meaning of health and disease (Stearns & Koella, 2008) from 
the standpoint of adaptation (or maladaptation), but also improve 
our understanding of the mechanisms underlying infectious disease 
transmission dynamics within social- ecological systems (Horwitz 
& Wilcox, 2005; Wilcox & Echaubard, 2016), context- dependent 
virulence and more effective treatment and control strategies 
(Echaubard, Sripa, Mallory, & Wilcox, 2016; Nesse, 2008; Restif, 
2009). As such, evolutionary biology as a framing approach and 
methodological toolkit is a needed component of integrated dis-
ease control and prevention (Allegranzi et al., 2017) and sustainable 
health development aligning with the recently adopted sustain-
able development goals (SDGs), as part of the 2030 Agenda for 
Sustainable Development (Carroll et al., 2014).
This special issue is an attempt to present an up- to- date appraisal 
of the challenges, current advances, and promising research avenues 
where evolutionary principles and their ecological corollaries can 
be applied in research as a basis for human infectious disease in-
terventions. Accordingly, the contributions published in this special 
issue together present an illustration of the diverse benefits of com-
bining biomedical and public health perspectives with evolutionary 
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causation in the context of infectious diseases for major infectious 
agents (Table 1).
2  | THEMES OF THE SPECIAL ISSUE
A main challenge of mainstreaming evolution into medicine and 
public health lies in the often very pragmatic and urgent nature of 
these fields (e.g., outbreak mitigation; Nesse & Stearns, 2008) and 
the relatively time- consuming nature of framing questions, interven-
tions, and policies following evolutionary principles, which imply a 
long- term preventive vision rather than a short- term curative do-
main of action. However, policy- oriented research and intervention 
informed by evolutionary biology have the potential to not only ef-
fectively mitigate urgent crises but also anticipate, minimize, and 
respond to the evolution of unwanted epidemiological traits (e.g., 
antimicrobial resistance). Accordingly, the articles compiled for this 
special issue present a selected panel of evolutionary applications 
for infectious disease control, together providing relevant avenues 
for future research and sustainable disease prevention strategies.
The articles published in this special issue are organized based on 
their underlying evolutionary innovation and public health implica-
tions and not necessarily on the disease study systems the authors 
are using to address their research questions. A range of disease 
systems, from macroparasites to microparasites (sensu Anderson 
& May, 1981), are examined through modeling, experimental and 
observational research designs as well as describing novel framing 
approaches.
As an opening paper, Kosoy and Kosoy (2017) explore the mul-
tiple dimensions and related complexity of host–pathogens interac-
tions revealed by the novel genetic and genomic data, along with 
extensive environmental parameters being acquired using newly de-
veloped computational tools. They highlight the need for flexibility in 
studying natural systems of zoonotic pathogens with respect to how 
we choose perspectives within a continuum between unrestricted 
diversity of related parameters and well- defined roles played by in-
fectious agents, potential and actual animal hosts, and environmen-
tal variables. They proposed a model of investigation that requires a 
dynamic shift of perspectives along the simplicity–complexity (‘sim-
plexity’) dimension emphasizing the difficulty to accommodate dual 
representations of both the subjective nature of investigations of 
zoonotic pathogens and much more objectively derived information, 
for example, coded in the genetic structure of DNA or in observing 
the morphology or behavior of bacteria. This also speaks directly to 
the issue of “problem framing” alluded to in this introduction where 
tools and perceptions emerging from biomedical sciences do not 
necessarily accommodate evolutionary- based predictions or public 
health implications.
Arguably the most widespread recognition of the importance of 
evolutionary biology for public health and medicine is in the con-
text of the emergence of resistance to antimicrobials and insecti-
cides. Sternberg and Thomas (2017) explore the overlaps between 
understanding and managing insecticide resistance in agriculture 
and in public health with the aim to identify best practices in resis-
tance mitigation strategies in the context of vector- borne disease 
interventions. They argue that the success of insecticide resistance 
management strategies is strongly dependent on the biological spe-
cifics of each system and that the biological, operational, and reg-
ulatory differences between agriculture and public health limit the 
wholesale transfer of knowledge and practices from one system 
to the other. Nonetheless, the authors argue that there are some 
valuable insights from agriculture that could assist in advancing the 
existing Global Plan for Insecticide Resistance Management (IRM). 
Accordingly, the authors suggest that for IRM strategies to succeed 
in public health, there needs to be a shift away from choosing vector 
control tools or strategies based on direct cost, toward factoring in 
the benefit of preserving susceptibility.
Focusing on Malaria, Huijben and Paaijmans (2017) analyze 
the evolutionary consequences of the way antimalarial drugs and 
insecticide- based interventions are currently implemented, which 
is leading to resistance and may ultimately lead to control failure. 
The authors describe how evolutionary principles can be applied to 
extend the lifespan of current and novel interventions highlighting 
in particular how understanding fitness costs arising from express-
ing, utilizing, and maintaining molecular or metabolic pathways of 
resistance will be essential to mitigate resistance evolution. They 
continue arguing that similar to insecticide resistance management 
strategies, large heterogeneity in drug exposure can be created in 
space (host mosaic) or time (drug rotation) or by deploying different 
compounds simultaneously (mixed treatment) and that better resis-
tance management is achieved if drugs can be combined that select 
for alternative allelic versions of the target locus.
Glunt et al. (2017) further discuss the challenges of insecti-
cide resistance in the context of malaria, with a specific focus on 
pyrethroids impregnated long- lasting insecticidal bed nets (LLINs) 
and their efficacy in preventing malaria. About 1 billion LLINs, a 
major vector control tool, have been distributed in Africa in the last 
10 years. During the same period of time resistance to pyrethroids in 
malaria mosquito vectors has increased significantly. Using a trans-
mission model, the authors show that when LLIN- related lethal and 
sublethal effects were accrued over mosquito lifetimes, they greatly 
reduced the impact of resistance on malaria transmission potential 
under conditions of high net coverage. However if coverage falls, the 
epidemiological impact is far more pronounced. Similarly, if the in-
tensity of resistance intensifies, the loss of malaria control increases 
nonlinearly. The authors argue that their findings help explain why 
insecticide resistance has not yet led to wide- scale failure of LLINs, 
as high distribution coverage is generally in place in most African 
endemic countries, but reinforce the call for alternative control tools 
and informed resistance management strategies.
While parasites can evolve classical resistance mechanisms 
(e.g., efflux pumps), it is also possible that changes in life- history 
traits could help parasites evade the effects of treatment. Birget, 
Greischar, Reece, and Mideo (2017) investigate how the life history 
of malaria parasites is governed by an intrinsic resource allocation 
problem where specialized stages are required for transmission, but 
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r 
or
ga
n 
im
pa
irm
en
t.
• 
Th
er
e 
is
 n
o 
sp
ec
ifi
c 
tr
ea
tm
en
t f
or
 
de
ng
ue
 fe
ve
r. 
M
ai
nt
en
an
ce
 o
f t
he
 
pa
tie
nt
’s 
bo
dy
 fl
ui
d 
vo
lu
m
e 
is
 c
rit
ic
al
 
to
 s
ev
er
e 
de
ng
ue
 c
ar
e.
• 
In
 la
te
 2
01
5 
an
d 
ea
rly
 2
01
6,
 th
e 
fir
st
 
de
ng
ue
 v
ac
ci
ne
, D
en
gv
ax
ia
 (C
YD
-
TD
V
) b
y 
Sa
no
fi 
Pa
st
eu
r, 
w
as
 
re
gi
st
er
ed
 in
 s
ev
er
al
 c
ou
nt
rie
s 
fo
r u
se
 
in
 in
di
vi
du
al
s 
9–
45
 y
ea
rs
 o
f a
ge
 li
vi
ng
 
in
 e
nd
em
ic
 a
re
as
.
• 
W
H
O
 re
co
m
m
en
ds
 th
at
 c
ou
nt
rie
s 
sh
ou
ld
 c
on
si
de
r i
nt
ro
du
ct
io
n 
of
 th
e 
de
ng
ue
 v
ac
ci
ne
 C
YD
-T
D
V
 o
nl
y 
in
 
ge
og
ra
ph
ic
al
 s
et
tin
gs
 w
he
re
 
ep
id
em
io
lo
gi
ca
l d
at
a 
in
di
ca
te
 a
 h
ig
h 
bu
rd
en
 o
f d
is
ea
se
.
A
t p
re
se
nt
, t
he
 m
ai
n 
m
et
ho
d 
to
 c
on
tr
ol
 
or
 p
re
ve
nt
 th
e 
tr
an
sm
is
si
on
 o
f 
de
ng
ue
 v
iru
s 
is
 to
 c
om
ba
t v
ec
to
r 
m
os
qu
ito
es
 th
ro
ug
h:
• 
Pr
ev
en
tin
g 
m
os
qu
ito
es
 fr
om
 
ac
ce
ss
in
g 
eg
g-
la
yi
ng
 h
ab
ita
ts
 b
y 
en
vi
ro
nm
en
ta
l m
an
ag
em
en
t a
nd
 
m
od
ifi
ca
tio
n
• 
D
is
po
si
ng
 o
f s
ol
id
 w
as
te
 a
nd
 
co
ve
rin
g,
 e
m
pt
yi
ng
, a
nd
 c
le
an
in
g 
of
 
do
m
es
tic
 w
at
er
 s
to
ra
ge
 c
on
ta
in
er
s 
on
 a
 w
ee
kl
y 
ba
si
s 
• 
A
pp
ly
in
g 
ap
pr
op
ria
te
 in
se
ct
ic
id
es
 to
 
w
at
er
 s
to
ra
ge
 o
ut
do
or
 c
on
ta
in
er
s 
an
d 
en
vi
ro
nm
en
ta
l m
an
ag
em
en
t
• 
U
si
ng
 o
f p
er
so
na
l h
ou
se
ho
ld
 
pr
ot
ec
tio
n 
su
ch
 a
s 
w
in
do
w
 s
cr
ee
ns
, 
lo
ng
-s
le
ev
ed
 c
lo
th
es
, i
ns
ec
tic
id
e-
tr
ea
te
d 
m
at
er
ia
ls
, c
oi
ls
, a
nd
 
va
po
riz
er
s;
• 
Im
pr
ov
in
g 
co
m
m
un
ity
 p
ar
tic
ip
at
io
n 
an
d 
m
ob
ili
za
tio
n 
fo
r s
us
ta
in
ed
 
ve
ct
or
 c
on
tr
ol
• 
In
cr
ea
si
ng
 p
op
ul
at
io
n 
m
ov
em
en
t, 
gl
ob
al
iz
at
io
n 
of
 
tr
ad
e 
an
d 
ur
ba
ni
za
tio
n 
w
ith
ou
t 
ad
eq
ua
te
 m
ea
su
re
s 
to
 p
re
ve
nt
 
ve
ct
or
 b
re
ed
in
g
• 
Ru
bb
er
 p
la
nt
at
io
ns
 e
xp
an
si
on
• 
M
os
qu
ito
 v
ec
to
r a
nd
 p
at
ho
ge
n 
ad
ap
ta
tio
n
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D
ia
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&
 t
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at
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t
Co
nt
ro
l s
tr
at
eg
y
Ch
al
le
ng
es
 fo
r c
on
tr
ol
In
flu
en
za
 
(z
oo
no
tic
)
• 
H
um
an
s 
ca
n 
be
 in
fe
ct
ed
 w
ith
 a
vi
an
, s
w
in
e,
 a
nd
 
ot
he
r z
oo
no
tic
 in
flu
en
za
 v
iru
se
s,
 s
uc
h 
as
 a
vi
an
 
in
flu
en
za
 v
iru
s 
su
bt
yp
es
 A
(H
5N
1)
, A
(H
7N
9)
, a
nd
 
A
(H
9N
2)
 a
nd
 s
w
in
e 
in
flu
en
za
 v
iru
s 
su
bt
yp
es
 
A
(H
1N
1)
, A
(H
1N
2)
, a
nd
 A
(H
3N
2)
.
• 
Th
e 
m
aj
or
ity
 o
f h
um
an
 c
as
es
 o
f i
nf
lu
en
za
 A
 
(H
5N
1)
 a
nd
 A
(H
7N
9)
 v
iru
s 
in
fe
ct
io
n 
ha
ve
 b
ee
n 
as
so
ci
at
ed
 w
ith
 d
ire
ct
 o
r i
nd
ire
ct
 c
on
ta
ct
 w
ith
 
in
fe
ct
ed
 li
ve
 o
r d
ea
d 
po
ul
tr
y.
 C
on
tr
ol
lin
g 
th
e 
di
se
as
e 
in
 th
e 
an
im
al
 s
ou
rc
e 
is
 c
rit
ic
al
 to
 
de
cr
ea
se
 ri
sk
 to
 h
um
an
s.
• 
A
qu
at
ic
 b
ird
s 
ar
e 
th
e 
pr
im
ar
y 
na
tu
ra
l r
es
er
vo
ir 
fo
r m
os
t s
ub
ty
pe
s 
of
 in
flu
en
za
 A
 v
iru
se
s.
 M
os
t 
ca
us
e 
as
ym
pt
om
at
ic
 o
r m
ild
 in
fe
ct
io
n 
in
 b
ird
s,
 
w
he
re
 th
e 
ra
ng
e 
of
 s
ym
pt
om
s 
de
pe
nd
s 
on
 th
e 
vi
ru
s 
pr
op
er
tie
s.
• 
V
iru
se
s 
th
at
 c
au
se
 s
ev
er
e 
di
se
as
e 
in
 p
ou
ltr
y 
an
d 
re
su
lt 
in
 h
ig
h 
de
at
h 
ra
te
s 
ar
e 
ca
lle
d 
hi
gh
ly
 
pa
th
og
en
ic
 a
vi
an
 in
flu
en
za
 (H
PA
I).
 V
iru
se
s 
th
at
 
ca
us
e 
m
ild
 d
is
ea
se
 in
 p
ou
ltr
y 
ar
e 
ca
lle
d 
lo
w
-p
at
ho
ge
ni
c 
av
ia
n 
in
flu
en
za
 (L
PA
I).
• 
Av
ia
n,
 s
w
in
e,
 a
nd
 o
th
er
 z
oo
no
tic
 
in
flu
en
za
 v
iru
s 
in
fe
ct
io
ns
 in
 h
um
an
s 
m
ay
 c
au
se
 d
is
ea
se
 ra
ng
in
g 
fr
om
 m
ild
 
up
pe
r r
es
pi
ra
to
ry
 tr
ac
t i
nf
ec
tio
n 
(fe
ve
r a
nd
 c
ou
gh
), 
ea
rly
 s
pu
tu
m
 
pr
od
uc
tio
n,
 a
nd
 ra
pi
d 
pr
og
re
ss
io
n 
to
 
se
ve
re
 p
ne
um
on
ia
, s
ep
si
s 
w
ith
 s
ho
ck
, 
ac
ut
e 
re
sp
ira
to
ry
 d
is
tr
es
s 
sy
nd
ro
m
e 
an
d 
ev
en
 d
ea
th
.
• 
La
bo
ra
to
ry
 te
st
s 
ar
e 
re
qu
ire
d 
to
 
di
ag
no
se
 h
um
an
 in
fe
ct
io
n 
w
ith
 
zo
on
ot
ic
 in
flu
en
za
.
• 
Ra
pi
d 
in
flu
en
za
 d
ia
gn
os
tic
 te
st
s 
(R
ID
Ts
) h
av
e 
lo
w
er
 s
en
si
tiv
ity
 
co
m
pa
re
d 
to
 P
C
R 
an
d 
th
ei
r r
el
ia
bi
lit
y 
de
pe
nd
s 
la
rg
el
y 
on
 th
e 
co
nd
iti
on
s 
un
de
r w
hi
ch
 th
ey
 a
re
 u
se
d.
• 
Ev
id
en
ce
 s
ug
ge
st
s 
th
at
 s
om
e 
an
tiv
ira
l 
dr
ug
s,
 n
ot
ab
ly
 n
eu
ra
m
in
id
as
e 
in
hi
bi
to
r (
os
el
ta
m
iv
ir,
 z
an
am
iv
ir)
, c
an
 
re
du
ce
 th
e 
du
ra
tio
n 
of
 v
ira
l r
ep
lic
at
io
n 
an
d 
im
pr
ov
e 
pr
os
pe
ct
s 
of
 s
ur
vi
va
l; 
ho
w
ev
er
, o
ng
oi
ng
 c
lin
ic
al
 s
tu
di
es
 a
re
 
ne
ed
ed
.
• 
In
 s
us
pe
ct
ed
 a
nd
 c
on
fir
m
ed
 c
as
es
, 
ne
ur
am
in
id
as
e 
in
hi
bi
to
rs
 s
ho
ul
d 
be
 
pr
es
cr
ib
ed
 a
s 
so
on
 a
s 
po
ss
ib
le
 to
 
m
ax
im
iz
e 
th
er
ap
eu
tic
 b
en
ef
its
.
• 
In
flu
en
za
 v
iru
se
s,
 w
ith
 th
e 
va
st
 
si
le
nt
 re
se
rv
oi
r i
n 
aq
ua
tic
 b
ird
s,
 a
re
 
im
po
ss
ib
le
 to
 e
ra
di
ca
te
.
• 
To
 m
in
im
iz
e 
pu
bl
ic
 h
ea
lth
 ri
sk
, 
qu
al
ity
 s
ur
ve
ill
an
ce
 in
 b
ot
h 
an
im
al
 
an
d 
hu
m
an
 p
op
ul
at
io
ns
, t
ho
ro
ug
h 
in
ve
st
ig
at
io
n 
of
 e
ve
ry
 h
um
an
 
in
fe
ct
io
n 
an
d 
ris
k-
ba
se
d 
pa
nd
em
ic
 
pl
an
ni
ng
 a
re
 e
ss
en
tia
l.
• 
A
pa
rt
 fr
om
 a
nt
iv
ira
l t
re
at
m
en
t, 
th
e 
pu
bl
ic
 h
ea
lth
 m
an
ag
em
en
t 
in
cl
ud
es
 p
er
so
na
l p
ro
te
ct
iv
e 
m
ea
su
re
s 
lik
e 
re
gu
la
r h
an
d 
w
as
hi
ng
, 
go
od
 re
sp
ira
to
ry
 h
yg
ie
ne
 a
nd
 e
ar
ly
 
se
lf-
is
ol
at
io
n 
of
 th
os
e 
fe
el
in
g 
un
w
el
l, 
fe
ve
ris
h 
an
d 
ha
vi
ng
 o
th
er
 
sy
m
pt
om
s 
of
 in
flu
en
za
.
• 
Pr
e-
ex
po
su
re
 o
r p
os
te
xp
os
ur
e 
pr
op
hy
la
xi
s 
w
ith
 a
nt
iv
ira
ls
 is
 
po
ss
ib
le
 b
ut
 d
ep
en
ds
 o
n 
se
ve
ra
l 
fa
ct
or
s,
 fo
r e
xa
m
pl
e,
 in
di
vi
du
al
 
fa
ct
or
s,
 ty
pe
 o
f e
xp
os
ur
e,
 a
nd
 ri
sk
 
as
so
ci
at
ed
 w
ith
 th
e 
ex
po
su
re
.
• 
In
te
rn
at
io
na
l m
ov
em
en
t o
f 
st
ra
in
s
• 
G
en
et
ic
 re
as
so
rt
m
en
ts
• 
Em
er
ge
nc
e 
of
 o
se
lta
m
iv
ir 
re
si
st
an
ce
 h
as
 b
ee
n 
re
po
rt
ed
.
• 
M
os
t r
ec
en
t A
(H
5)
 a
nd
 
A
(H
7N
9)
 v
iru
se
s 
ar
e 
re
si
st
-
an
t t
o 
ad
am
an
ta
ne
 a
nt
iv
ira
l 
dr
ug
s 
(e
.g
., 
am
an
ta
di
ne
 a
nd
 
rim
an
ta
di
ne
) a
nd
 a
re
 th
er
ef
or
e 
no
t r
ec
om
m
en
de
d 
fo
r 
m
on
ot
he
ra
py
.
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Co
nt
ro
l s
tr
at
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y
Ch
al
le
ng
es
 fo
r c
on
tr
ol
C
ha
ga
s 
di
se
as
ec
• 
C
ha
ga
s 
di
se
as
e,
 a
ls
o 
kn
ow
n 
as
 A
m
er
ic
an
 
tr
yp
an
os
om
ia
si
s,
 is
 a
 p
ot
en
tia
lly
 li
fe
-t
hr
ea
te
ni
ng
 
ill
ne
ss
 c
au
se
d 
by
 th
e 
pr
ot
oz
oa
n 
pa
ra
-
si
te
 T
ry
pa
no
so
m
a 
cr
uz
i (
T.
 c
ru
zi)
.
• 
A
bo
ut
 6
 m
ill
io
n 
to
 7
 m
ill
io
n 
pe
op
le
 w
or
ld
w
id
e 
ar
e 
es
tim
at
ed
 to
 b
e 
in
fe
ct
ed
 w
ith
 T
ry
pa
ns
os
om
a 
cr
uz
i.
• 
C
ha
ga
s 
di
se
as
e 
is
 fo
un
d 
m
ai
nl
y 
in
 e
nd
em
ic
 a
re
as
 
of
 2
1 
La
tin
 A
m
er
ic
an
 c
ou
nt
rie
s,
 w
he
re
 it
 is
 
m
os
tly
 v
ec
to
r-
bo
rn
e 
tr
an
sm
itt
ed
 to
 h
um
an
s 
by
 
co
nt
ac
t w
ith
 fe
ce
s 
or
 u
rin
e 
of
 tr
ia
to
m
in
e 
bu
gs
• 
C
ha
ga
s 
di
se
as
e 
oc
cu
rs
 p
rin
ci
pa
lly
 in
 th
e 
co
nt
in
en
ta
l p
ar
t o
f L
at
in
 A
m
er
ic
a 
an
d 
no
t i
n 
th
e 
C
ar
ib
be
an
 is
le
s.
 In
 th
e 
pa
st
 d
ec
ad
es
, h
ow
ev
er
, i
t 
ha
s 
be
en
 in
cr
ea
si
ng
ly
 d
et
ec
te
d 
in
 th
e 
U
ni
te
d 
St
at
es
 o
f A
m
er
ic
a,
 C
an
ad
a,
 a
nd
 m
an
y 
Eu
ro
pe
an
 
an
d 
so
m
e 
W
es
te
rn
 P
ac
ifi
c 
co
un
tr
ie
s.
 T
hi
s 
is
 d
ue
 
m
ai
nl
y 
to
 p
op
ul
at
io
n 
m
ob
ili
ty
 b
et
w
ee
n 
La
tin
 
A
m
er
ic
a 
an
d 
th
e 
re
st
 o
f t
he
 w
or
ld
.
• 
C
ha
ga
s 
di
se
as
e 
ca
n 
be
 tr
ea
te
d 
w
ith
 
be
nz
ni
da
zo
le
 a
nd
 a
ls
o 
ni
fu
rt
im
ox
.
• 
Bo
th
 m
ed
ic
in
es
 a
re
 a
lm
os
t 1
00
%
 
ef
fe
ct
iv
e 
in
 c
ur
in
g 
th
e 
di
se
as
e 
if 
gi
ve
n 
so
on
 a
ft
er
 in
fe
ct
io
n 
at
 th
e 
on
se
t o
f 
th
e 
ac
ut
e 
ph
as
e 
in
cl
ud
in
g 
th
e 
ca
se
s 
of
 
co
ng
en
ita
l t
ra
ns
m
is
si
on
. T
he
 e
ff
ic
ac
y 
of
 b
ot
h 
di
m
in
is
he
s,
 h
ow
ev
er
, t
he
 
lo
ng
er
 a
 p
er
so
n 
ha
s 
be
en
 in
fe
ct
ed
.
• 
Th
e 
po
te
nt
ia
l b
en
ef
its
 o
f m
ed
ic
at
io
n 
in
 p
re
ve
nt
in
g 
or
 d
el
ay
in
g 
th
e 
de
ve
lo
pm
en
t o
f C
ha
ga
s 
di
se
as
e 
sh
ou
ld
 b
e 
w
ei
gh
ed
 a
ga
in
st
 th
e 
lo
ng
 
du
ra
tio
n 
of
 tr
ea
tm
en
t (
up
 to
 2
 m
on
th
s)
 
an
d 
po
ss
ib
le
 a
dv
er
se
 re
ac
tio
ns
 
(o
cc
ur
rin
g 
in
 u
p 
to
 4
0%
 o
f t
re
at
ed
 
pa
tie
nt
s)
.
• 
Th
e 
co
st
 o
f t
re
at
m
en
t f
or
 C
ha
ga
s 
di
se
as
e 
re
m
ai
ns
 s
ub
st
an
tia
l. 
In
 
C
ol
om
bi
a 
al
on
e,
 th
e 
an
nu
al
 c
os
t o
f 
m
ed
ic
al
 c
ar
e 
fo
r a
ll 
pa
tie
nt
s 
w
ith
 th
e 
di
se
as
e 
w
as
 e
st
im
at
ed
 to
 b
e 
ab
ou
t U
S 
26
7 
m
ill
io
n 
in
 2
00
8.
 S
pr
ay
in
g 
in
se
ct
ic
id
e 
to
 c
on
tr
ol
 v
ec
to
rs
 w
ou
ld
 
co
st
 n
ea
rly
 U
S 
5 
m
ill
io
n 
an
nu
al
ly
—
le
ss
 
th
an
 2
%
 o
f t
he
 m
ed
ic
al
 c
ar
e 
co
st
.
• 
Th
er
e 
is
 n
o 
va
cc
in
e 
fo
r C
ha
ga
s 
di
se
as
e.
• 
Ve
ct
or
 c
on
tr
ol
 is
 th
e 
m
os
t e
ff
ec
tiv
e 
m
et
ho
d 
of
 p
re
ve
nt
io
n 
in
 L
at
in
 
A
m
er
ic
a.
 B
lo
od
 s
cr
ee
ni
ng
 is
 
ne
ce
ss
ar
y 
to
 p
re
ve
nt
 in
fe
ct
io
n 
th
ro
ug
h 
tr
an
sf
us
io
n 
an
d 
or
ga
n 
tr
an
sp
la
nt
at
io
n.
• 
Th
e 
co
nt
ro
l t
ar
ge
ts
 a
re
 e
lim
in
at
io
n 
of
 th
e 
tr
an
sm
is
si
on
 a
nd
 e
ar
ly
 
he
al
th
ca
re
 a
cc
es
s 
fo
r t
he
 in
fe
ct
ed
 
an
d 
ill
 p
op
ul
tio
n.
• 
D
ep
en
di
ng
 o
n 
th
e 
ge
og
ra
ph
ic
al
 
ar
ea
, W
H
O
 re
co
m
m
en
ds
 th
e 
fo
llo
w
in
g 
ap
pr
oa
ch
es
 to
 p
re
ve
nt
io
n 
an
d 
co
nt
ro
l: 
o 
Sp
ra
yi
ng
 o
f h
ou
se
s 
an
d 
su
rr
ou
nd
in
g 
ar
ea
s 
w
ith
 re
si
du
al
 
in
se
ct
ic
id
es
o 
H
ou
se
 im
pr
ov
em
en
ts
 a
nd
 h
ou
se
 
cl
ea
nl
in
es
s 
to
 p
re
ve
nt
 v
ec
to
r 
in
fe
st
at
io
n;
o 
Be
dn
et
s
• 
Ps
yc
ho
-s
oc
ia
l c
ha
lle
ng
es
 s
uc
h 
as
 s
tig
m
a 
re
la
te
d 
to
 p
ov
er
ty
 
an
d 
em
ot
io
na
l f
ea
rs
 o
f b
ei
ng
 
ju
dg
ed
 le
ad
in
g 
to
 lo
w
 re
po
rt
in
g 
an
d 
sc
re
en
in
g
• 
In
cr
ea
si
ng
 in
se
ct
ic
id
e 
re
si
st
an
ce
 o
f T
ria
to
m
in
e 
ve
ct
or
s 
an
d 
ra
pi
d 
re
co
lo
ni
sa
-
tio
n 
of
 h
ou
se
ho
ld
s 
by
 v
ec
to
rs
 
af
te
r s
pr
ay
in
g
• 
D
ia
gn
os
is
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at
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y
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r c
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Sc
hi
st
os
om
ia
si
sd
• 
Sc
hi
st
os
om
ia
si
s 
is
 a
n 
ac
ut
e 
an
d 
ch
ro
ni
c 
pa
ra
si
tic
 
di
se
as
e 
ca
us
ed
 b
y 
bl
oo
d 
flu
ke
s 
(tr
em
at
od
e 
w
or
m
s)
 o
f t
he
 g
en
us
 S
ch
ist
os
om
a.
• 
Es
tim
at
es
 s
ho
w
 th
at
 a
t l
ea
st
 2
06
.4
 m
ill
io
n 
pe
op
le
 
re
qu
ire
d 
pr
ev
en
tiv
e 
tr
ea
tm
en
t i
n 
20
16
.
• 
Sc
hi
st
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producing these stages comes at the cost of producing fewer of the 
forms required for within- host survival. The underlying rationale is 
that drug treatment, by design, alters the probability of within- host 
survival and so should alter the costs and benefits of investing in 
transmission. The authors use a within- host model of malaria infec-
tion to predict optimal patterns of investment in transmission in the 
face of different drug treatment regimens and determine the extent 
to which alternative patterns of investment can buffer the fitness 
loss due to drugs. This work emphasizes that in addition to classical 
resistance mechanisms, drug treatment generates selection for al-
tered parasite life history. It also suggests that understanding how 
any shifts in life history will alter the efficacy of drugs, as well as any 
limitations on such shifts, is important for evaluating and predicting 
the consequences of drug treatment.
While evolutionary principles can help design more sustain-
able insecticide and antimicrobial resistance mitigation strategies, 
evaluating the risk of emergence and transmission of vector- borne 
diseases also requires knowledge of the genetic and environmental 
contributions to pathogen transmission traits. In their perspective 
article, Lefevre et al. (2017) discuss how the associations between 
malaria parasites transmission traits and their related trade- offs and 
constraints could have important implications for understanding the 
evolution of parasite transmission and how so doing could inform 
disease control. For instance, they argue, frontline vector- borne 
disease prevention tools such as insecticide- treated bednets and in-
door residual spraying rely on reducing mosquito contact rates with 
human hosts and reducing vector survival. Reduced vector survival 
has the benefits of decreasing mosquito abundance, the number of 
bites a mosquito can take over the course of its lifetime, and the 
probability that mosquitoes survive past the parasite’s development 
time. These effects likely shape the selective environment for para-
sites within the vector. However, whether parasites can respond to 
interventions by evolving shorter EIPs or other heritable extended 
phenotypes that lengthen mosquito survival or change vector be-
havior merit further investigation.
As in the case of malaria described by Lefevre et al. (2017), life- 
history trait evolution theory and its attributes can help better un-
derstand the adaptive potential of triatomines—the vector of Chagas 
disease. The review by Flores- Ferrer, Marcou, Waleckx, Dumonteil, 
and Gourbière (2017) suggests that current knowledge of the deter-
minants of high diversity and low virulence of the Trypanosoma cruzi 
parasite remains too limiting to design evolution- proof strategies, 
while such attributes may be part of the future of Chagas disease 
control after the 2020 WHO’s target of regional elimination of intra-
domiciliary transmission has been reached. The authors argue that 
the eco- epidemiological relationships that build- up the selective 
pressures at work have been assiduously studied over the last cen-
tury, so that, combined with concepts and modeling inspired from 
life- history evolution, a good evolutionary understanding could be 
rapidly gained. Although more specific information will surely be 
needed, the authors suggest that an effective research strategy 
would be to integrate data into the conceptual and theoretical frame-
work of evolutionary ecology and life- history evolution to provide 
the quantitative backgrounds necessary to understand and possibly 
anticipate adaptive responses to public health interventions.
Public health interventions targeting helminth diseases often 
rely on mass drug administration to reduce human morbidity and 
mortality. Considering the frequency of such interventions and the 
strength of the selective pressure they impose, the emergence and 
spread of drug resistance is a concern. In the case of schistosomiasis, 
although hotspots of reduced efficacy of the drug praziquantel have 
been reported, resistance is not widespread. However, parasite pop-
ulations often exhibit considerable genetic variability in their natural 
tolerance, or acquired resistance, to drugs which, as Viana, Faust, 
Haydon, Webster, and Lamberton (2017) emphasize, is related to the 
fitness costs associated with such resistance compared to suscepti-
ble lines. Using Bayesian state- space models (SSMs) fitted to data 
from an in vivo laboratory system, the authors tested the hypothesis 
that the spread of resistant Schistosoma mansoni may be limited by 
life- history costs not present in susceptible counterparts. S. man­
soni parasites from a praziquantel- susceptible (S), a praziquantel- 
resistant (R) or a mixed line of originally resistant and susceptible 
parasites (RS) were exposed to a range of praziquantel doses. Results 
showed that parasite adult worm survival and fecundity in the mu-
rine host decreased across all lines, including R, with increasing drug 
pressure. The authors also observed trade- offs between adult sur-
vival and fecundity in all untreated lines, and these remained strong 
in S with praziquantel pressure. In contrast, trade- offs between 
adult survival and fecundity were lost under praziquantel pressure 
in R. Additionally the authors showed that life- history traits within 
the molluscan intermediate host were complex, but trade- offs were 
demonstrated between parasite establishment and cercarial output. 
These results have theoretical and applied implications and appli-
cations for future schistosomiasis control programs and for other 
host–parasite treatment programs in general.
Complementing the work by Viana et al., 2017; Borlase, Webster, 
and Rudge (2017) present the case example of haematobium group 
Schistosoma spp. hybrids in West Africa, a system involving multiple 
interacting parasites and multiple definitive hosts, in a region where 
zoonotic reservoirs of schistosomiasis were not previously consid-
ered to be of importance. The authors consider how existing math-
ematical model frameworks for schistosome transmission could be 
expanded and adapted to zoonotic hybrid systems, exploring how 
such model frameworks can utilize molecular and epidemiological 
data, as well as the complexities and challenges this presents. The 
authors also highlight the opportunities and value such mathematical 
models could bring to this and a similar multihost, multiparasite sys-
tems, including informing priorities for data collection, diagnostics 
and laboratory studies and exploring the impact that hybridizations 
may have on control measures, as well the impact that evolutionary 
pressures including control measures may have on driving the emer-
gence and spread of parasite hybrids.
Evolutionary- based mathematical modeling is also increasingly 
used to enhance both understanding and design of integrated inter-
vention in the context of microparasites such as Dengue. Lourenço 
et al. (2017) review and analyze the biological and epidemiological 
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background of dengue, together with the major achievements of 
computational approaches including highlighting critical knowl-
edge gaps and research underachievements that call for an urgent 
renewed focus. The authors argue that possible advancements 
based on new processing strategies, including real- time computa-
tional analysis of genetic data, phylodynamic modeling frameworks, 
within- host model frameworks and GPU accelerated computing al-
ready implemented for other pathogens, are already at reach of the 
Dengue research community. These new approaches are expected 
to make a significant contribution to our understanding of the evo-
lutionary ecology and immunology of the dengue virus and support 
the design of novel integrated control strategies adaptable to other 
microparasite systems such as avian influenza affecting domestic 
animals and humans alike.
Influenza pandemics represent a significant threat to global 
public health. Four major pandemics have been recorded since the 
1900s, occurring in 1918, 1957, 1968, and 2009 when influenza A vi-
ruses with genes from animal sources adapted to the human popula-
tion, a process known as antigenic shift. The H1N1/2009 pandemic 
virus emerged from swine that contained gene segments ultimately 
derived from previously circulating human and avian viruses, high-
lighting a key role of segmental reassortment of genes from multiple 
hosts for host adaption and pandemic emergence. In this context, 
Joseph, Vijaykrishna, Smith, and Su (2017) used a relaxed molec-
ular clock model to test whether the European avian- like swine 
(EA- swine) influenza virus originated through the introduction of a 
single avian ancestor as an entire genome, followed by an analysis 
of host- specific selection pressures among different gene segments. 
The results indicate independent introduction of gene segments 
via transmission of avian viruses into swine followed by reassort-
ment events that occurred at least 1–4 years prior to the EA- swine 
outbreak. All EA- swine gene segments exhibited greater selection 
pressure than avian viruses, reflecting both adaptive pressures and 
relaxed selective constraints that are associated with host switching. 
Key amino acid mutations in the viral surface proteins (H1 and N1) 
that play a role in adaptation to new hosts were also observed sug-
gesting adaptive changes in viral genomes following the transmis-
sion of avian influenza viruses to swine and the early establishment 
of the EA- swine lineage.
Complementing the work by Joseph et al., 2017;  Grear, Hall, 
Dusek, and Ip (2017) investigated mechanisms of intercontinental 
highly pathogenic avian influenza virus (HPAIV) spread through wild 
bird reservoirs possibly related to the North America outbreak in 
2014. This introduction resulted in several reassortment events 
with North American (NA) lineage low- pathogenic avian influenza 
viruses and the reassortant EA/NA H5N2 that went on to cause 
one of the largest HPAIV poultry outbreaks in North America. In 
their research article, the authors used a time- rooted phylodynamic 
model that explicitly incorporated viral population dynamics with 
evolutionary dynamics to estimate the basic reproductive number 
(R0) and viral migration among host types in domestic and wild birds, 
as well as between the EA H5N8 and EA/NA H5N2 in wild birds. 
While the authors did not find evidence to support the hypothesis 
that transmission of novel HPAIVs in wild birds was restricted by 
mechanisms associated with highly pathogenic phenotypes or that 
the HPAIV poultry outbreak was self- sustaining and required viral 
input from wild birds, the model estimates of the transmission pa-
rameters suggested that the HPAIV outbreak met or exceeded the 
threshold	for	persistence	in	wild	birds	(R0	>	1)	and	poultry	(R0	≈	1).	
Overall, the results of this work suggest that this novel HPAIV and 
reassortments did not encounter any transmission barriers sufficient 
to prevent persistence when introduced to wild or domestic birds 
and highlight the relevance of phylodynamic methods to test hy-
potheses about geographical spread of AIVs in wild birds, multiyear 
evolutionary processes of AIVs in reservoir hosts and relative fitness 
of highly pathogenic versus low- pathogenic AIVs in wild birds for 
more integrated surveillance systems.
3  | CLOSING REMARKS: E VOLUTION, 
ADAPTIVE MANAGEMENT, AND 
SUSTAINABLE HE ALTH DE VELOPMENT
While disease control and prevention have achieved great successes, 
the paradigm within which it has been developed, including our un-
derstanding of host–parasite relationships, infection, and disease, 
as well as best management practices, arguably is not enough. A 
major shortcoming is that the solutions it provides, often grounded 
in the curative domain, are not lasting. Evolutionary thinking applied 
to medical and public health problems promises to substitute the 
short- sighted use of drugs with sustainable solutions: If we cannot 
eradicate infections by frontal assault, we may be able to keep them 
at bay durably provided we can understand the fundamental nature 
of host–parasite relationships.
The evolutionary perspective asks ultimate questions, which are 
about why mechanisms or epidemiological phenotypes are the way 
they are (i.e., how has this mechanism given a selective advantage? 
what is the evolutionary history of this mechanism?). Most medical 
research and perspectives focus on proximal questions, questions 
about the mechanisms themselves (i.e., how does the mechanism 
work, what is the ontogeny of the mechanisms?). The distinction be-
tween proximate (mechanistic) and ultimate (evolutionary) explana-
tions was emphasized and formalized several decades ago but remain 
unfamiliar to the medical sciences and public health domain despite 
its epistemological importance (Nesse, 2013). Both types of expla-
nations are necessary, neither substitutes for the other, and they in-
form each other (Nesse, 2013; Nesse & Stearns, 2008). Incorporating 
evolutionary thinking in infectious disease research helps improving 
our understanding of diseases transmission dynamics, infection pat-
terns, and disease manifestation trends by superimposing a context- 
dependent, systems dynamics prism that appreciates that organisms 
and their interactions are in constant flux (Levin, 1998). Accordingly, 
evolutionary biology can help identify new relevant questions such 
as the ones addressed in this special issue, and doing so, can help 
inform more integrated disease control interventions as well as more 
adaptive health management strategies.
392  |     EDITORIAL
Adaptive health management, standing on strong evolutionary 
foundations, has the potential to address two fundamental errors 
underpinning most current public health interventions targeting in-
fectious diseases. The first error is often the implicit assumption that 
pathogens or parasite responses to human intervention and/or that 
human–parasite/pathogens interactions are linear, predictable, and 
controllable. The second error is the assumption that pathogens and 
parasites can be treated independently of the social- ecological sys-
tem within which they evolve (Horwitz & Wilcox, 2005). By explicitly 
avoiding these errors, evolutionary- based adaptive health manage-
ment could help strengthen the representation of the operational 
concept of resilience in public health and restore the health systems 
capacity to buffer infectious and noninfectious challenges, learn, 
and develop—as a framework for understanding how to sustain and 
enhance adaptive capacity in a complex world of rapid transforma-
tions (Folke et al., 2002).
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